SE404376B - Framstellning av en blandning av 3-tiometulrifamycin s, 3-tiometylrifamycin sv, rifamycin s, rifamycin sv och en ny ansamycin betecknad 32 656 genom odling av en mikroorganism benemnd micromonospora lacustris sp nov ... - Google Patents

Framstellning av en blandning av 3-tiometulrifamycin s, 3-tiometylrifamycin sv, rifamycin s, rifamycin sv och en ny ansamycin betecknad 32 656 genom odling av en mikroorganism benemnd micromonospora lacustris sp nov ...

Info

Publication number
SE404376B
SE404376B SE7414855A SE7414855A SE404376B SE 404376 B SE404376 B SE 404376B SE 7414855 A SE7414855 A SE 7414855A SE 7414855 A SE7414855 A SE 7414855A SE 404376 B SE404376 B SE 404376B
Authority
SE
Sweden
Prior art keywords
rifamycin
thiometulrifamycin
thiomethylrifamycin
novenom
benomosph
Prior art date
Application number
SE7414855A
Other languages
English (en)
Other versions
SE7414855L (sv
Inventor
W D Celmer
F C Sciavolino
J B Routien
W P Cullen
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of SE7414855L publication Critical patent/SE7414855L/xx
Publication of SE404376B publication Critical patent/SE404376B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07G—COMPOUNDS OF UNKNOWN CONSTITUTION
    • C07G11/00—Antibiotics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/863—Mycobacterium

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Saccharide Compounds (AREA)
SE7414855A 1974-01-09 1974-11-26 Framstellning av en blandning av 3-tiometulrifamycin s, 3-tiometylrifamycin sv, rifamycin s, rifamycin sv och en ny ansamycin betecknad 32 656 genom odling av en mikroorganism benemnd micromonospora lacustris sp nov ... SE404376B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US431845A US3914218A (en) 1974-01-09 1974-01-09 3-Methylthiorifamycins

Publications (2)

Publication Number Publication Date
SE7414855L SE7414855L (sv) 1975-07-10
SE404376B true SE404376B (sv) 1978-10-02

Family

ID=23713694

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7414855A SE404376B (sv) 1974-01-09 1974-11-26 Framstellning av en blandning av 3-tiometulrifamycin s, 3-tiometylrifamycin sv, rifamycin s, rifamycin sv och en ny ansamycin betecknad 32 656 genom odling av en mikroorganism benemnd micromonospora lacustris sp nov ...

Country Status (24)

Country Link
US (1) US3914218A (sv)
JP (1) JPS5748198B2 (sv)
AR (1) AR207344A1 (sv)
AT (1) AT338970B (sv)
BE (1) BE824104A (sv)
CA (1) CA1033674A (sv)
CH (1) CH596311A5 (sv)
CS (1) CS191924B2 (sv)
DD (1) DD115917A5 (sv)
DE (1) DE2500898A1 (sv)
DK (1) DK137841B (sv)
ES (1) ES433631A1 (sv)
FI (1) FI53983C (sv)
FR (1) FR2256756B1 (sv)
GB (1) GB1478469A (sv)
HU (1) HU173914B (sv)
IE (1) IE40205B1 (sv)
IL (1) IL46268A (sv)
LU (1) LU71608A1 (sv)
NL (1) NL7500200A (sv)
PL (1) PL94189B1 (sv)
RO (1) RO63768A (sv)
SE (1) SE404376B (sv)
SU (1) SU575038A3 (sv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4344934A (en) * 1978-11-20 1982-08-17 American Home Products Corporation Therapeutic compositions with enhanced bioavailability
JPS5653682A (en) * 1979-10-09 1981-05-13 Kanebo Ltd Production of novel rifamycin derivative
US4877735A (en) * 1987-06-19 1989-10-31 Takeda Chemical Industries, Ltd. Process for producing 2-keto-L-gulonic acid
USD874704S1 (en) 2016-07-26 2020-02-04 Solar Eco Systems Solar light
USD870945S1 (en) 2016-07-26 2019-12-24 Solar Eco Systems Solar light
CN116768910B (zh) * 2023-08-18 2023-10-31 山东齐都药业有限公司 一种利福布汀的精制方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1165179A (en) * 1966-10-25 1969-09-24 Lepetit Spa Derivatives of Rifamycin SV

Also Published As

Publication number Publication date
FI53983B (fi) 1978-05-31
IE40205L (en) 1975-07-09
FI53983C (fi) 1978-09-11
GB1478469A (en) 1977-06-29
FI750038A (sv) 1975-07-10
DK673174A (sv) 1975-09-01
IE40205B1 (en) 1979-04-11
AU7681374A (en) 1976-06-24
CA1033674A (en) 1978-06-27
NL7500200A (nl) 1975-07-11
AR207344A1 (es) 1976-09-30
FR2256756B1 (sv) 1978-06-30
CH596311A5 (sv) 1978-03-15
ES433631A1 (es) 1977-02-16
SE7414855L (sv) 1975-07-10
RO63768A (fr) 1978-12-15
DK137841B (da) 1978-05-16
IL46268A (en) 1977-06-30
LU71608A1 (sv) 1975-12-09
ATA9575A (de) 1977-01-15
CS191924B2 (en) 1979-07-31
JPS50100293A (sv) 1975-08-08
IL46268A0 (en) 1975-05-22
SU575038A3 (ru) 1977-09-30
AT338970B (de) 1977-09-26
HU173914B (hu) 1979-09-28
DE2500898A1 (de) 1975-07-17
US3914218A (en) 1975-10-21
DD115917A5 (sv) 1975-10-20
FR2256756A1 (sv) 1975-08-01
BE824104A (fr) 1975-07-07
PL94189B1 (sv) 1977-07-30
JPS5748198B2 (sv) 1982-10-14
DK137841C (sv) 1978-10-16

Similar Documents

Publication Publication Date Title
SE420215B (sv) Framstellning av ett nytt antibiotikum benemnt fortimioin a genom odling av mikromonospora olivoasterospora atcc 21819, 31009 eller 31010 samt isolering
NL7410444A (nl) Cyclohexaanderivaten alsmede een werkwijze voor de bereiding ervan.
NL7416715A (nl) Nieuwe verbindingen van 2-cyclohexeen-1-on-deri- vaten, werkwijze voor de bereiding ervan alsmede de toepassing ervan als selectief herbicide.
SE7611906L (sv) Ny organisk forening, framstellning och anvendning derav.
FR2278999A1 (fr) Ensemble d'anneaux d'etancheite
NL7611806A (nl) (1-fenyl-2-triazolylethyl)-etherderivaten, werk- wijzen ter bereiding en de toepassing als fungi- cide ervan.
SE391513B (sv) Forfarande for framstellning av en sic1?71 och sihc1?3 innehallande gasblandning
SE435635B (sv) Forfarande for framstellning av ett nytt antibiotiskt antracyklinkomplex, betecknat bohemsyrakomplex, och dess bestandsdelar, kallade musettamycin och marcellomycin, genom odling av den nya stammen actinosporangium sp.
SE420506B (sv) Forfarande for framstellning av zeaxantin genom odling av flavobacter i nervaro av bl a pyridoxin och viss halt av fe?7222 fe?722+, co?7222 co?722+, mo?7222 mo?722+ eller mn?7222 mn?722+
SE431227B (sv) Forfarande for framstellning av ett glukosisomerasenzym med god vermestabilitet och lagringsbestendighet genom odling av stammar av bacillus coagualans
SE404376B (sv) Framstellning av en blandning av 3-tiometulrifamycin s, 3-tiometylrifamycin sv, rifamycin s, rifamycin sv och en ny ansamycin betecknad 32 656 genom odling av en mikroorganism benemnd micromonospora lacustris sp nov ...
SE431100B (sv) Forfarande for framstellning av nya rifamyciner benemnda rifamycin p, q, r och u genom odling av nya stammar av nocardia mediterranea
NL7506636A (nl) Vlambestendig thermoplastisch mengsel en werk- wijze voor de bereiding daarvan.
SE7703974L (sv) 1,3,4-tiadiazolylderivat till anvendning som herbicider och sett att framstella foreningarna
NL7505672A (nl) Nieuwe diaminen, werkwijze ter bereiding en toepassing hiervan.
SE385713B (sv) Framstellning av 7beta -(d-5-amino-5-karboxivaleramido)-3-(karbamoyloximetyl)-7-metoxi-3-cefem-4-karbonsyra genom odling av en ny mikroorganism benemd streptomyces lactamdurans nrrl 3802
SE436575B (sv) Forfarande for framstellning av kreatinin-desimidas genom odling av nya stammar tillhorande slekterna brevibacterium, corynebacterium, pseudomonas och arthrobacter
SE420505B (sv) Forfarande for framstellning av zeaxantin genom odling av flavobacter i nervaro av metionin, cystin och/eller cystein samt viss halt av fe?7222 fe?722+, co?7222 co?722+, mo?7222 mo?722+ eller mn?7222 mn?722+
SE418048B (sv) Herbicid innehallande en blandning av 1,1,1-trifluor-4?721-(fenylsulfonyl) metansulfon-o-toluidid och 1-fenyl-4-amino-5-klorpyridazon-6
SE390542B (sv) Framstellning av ett nytt antibiotikum kallat a-2315 genom odling av en ny stam av actinoplanes philippinensis (nrrl 5462)
SE420214B (sv) Framstellning av ett nytt antibiotikum benemt fortimicin b genom odling av micromonospora olivoasterospora atcc 21819, 31009 eller 31010 samt isolering
NL7500788A (nl) Nieuwe spiraanderivaten, alsmede werkwijze voor reiding en toepassing daarvan.
NO142789C (no) Fremgangsmaate for fremstilling av et polypeptidantibiotikum, gardimycin.
PL196355A1 (pl) Sposob mikrobiologicznego wytwarzania mieszaniny androstadieno-1,4-dionu-3,17 i androsteno-4-dionu-3,17
SE7508005L (sv) Forfarande for framstellning av 1-metylpiperazin och 1,4-dimetylpiperazin.

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7414855-2

Effective date: 19891114

Format of ref document f/p: F